Tämä sivu käännettiin automaattisesti, eikä käännösten tarkkuutta voida taata. Katso englanninkielinen versio lähdetekstiä varten.

How to Develop a Training Program for Nurses in Ultrasound Guided Femoral Nerve Block

keskiviikko 2. joulukuuta 2020 päivittänyt: Espen Lindholm, Sykehuset i Vestfold HF

How to Develop a Training Program for Nurses in Ultrasound Guided Femoral - a Methodology Study

In this study the intervention consists of a one-day-training program for nurses and three supervised ultrasound guided femoral nerve block (UGFNB) per registered nurse.

The training consists of an instruction movie, one-day on-site-simulation and practical examination. The nurses are watching an instruction video and review current local guidelines for UGFNB in advance. The one-day training is situated in a simulation center and consists of theoretical and practical training divided into; infection prevention, anatomy, use of ultrasound and prevention and treatment of complications. A ultrasound model (Gen II Femoral Vascular Access and Regional Anesthesia Ultrasound Training Model) and a living human model is used to examine the femoral nerve and the neighboring structures using ultrasound. At the end of the one-day course, the nurses attends a practical examination with the researchers and anesthesiologists observing, to assure that they could perform the UGFNB procedure correctly. To pass the exam and be able to move on to the supervised blocks in real patients, there has to be a consensus between the researchers and anesthesiologist that they had sufficient knowledge and practical skills. 1) Sterile procedure 2) Management of the ultrasound machine and oral description of the anatomic surroundings in the groin area 3) Preparation of the local anesthetics and performance of an UGFNB. They also have to do an oral presentation in how they would perform a cardiopulmonary resuscitation procedure and how to manage complications / toxic reactions. Approved exam required at least seven points. This study will explore if a one-day course as described above is adequate, sufficient and maintains the safety framework of performing UGFNB in nurses

Tutkimuksen yleiskatsaus

Yksityiskohtainen kuvaus

Acute pain is a common reason for patients admitted to Emergency Departments (ED) . Globally over 1 million hip fractures occur yearly , a trauma that is close related with acute distinct pain in the proximal part of the affected extremity. Experiencing severe pain is associated with increased length of stay, higher risk of delirium, movement restriction, difficulties with mobilization and reduced health related quality of life. There is considerable research regarding patients' satisfaction with their ED experiences. These studies indicate that patient dissatisfaction with the stay at ED has been an international challenge over several years . Disapproval such as; pain management , but also limited information on potential latency before further treatment and poor explanation about the causes and treatment of the condition is prominent.

Pain control can be difficult , and often requires advanced nursing and physician care due to co-morbidity . Inadequate analgesia appear to be risk factors for delirium in frail older adults, and research indicates that total avoiding opioids or using very low or high doses of opioids may increase the risk of delirium. Therefore, optimizing acute pain management is important. Ultrasound Guided Femoral Nerve block (UGFNB) performed in hip fracture patients is a valuable alternative to systemic analgesic, as it provides analgesia to the fractured area, thereby facilitating reduction in opioid administration. Traditionally, an UGFNB is performed by an anesthesiologist. Recently, several examples of task shifting from physicians to nurses are described with no significant difference in successful treatment results with equal patients satisfaction and safety as physician performed procedures. Task shifting approach is endorsed by the World Health Organization (WHO) in order to make more efficient use of the available human resource of health. A recent report from the European Union (EU) states that implementation of task shifting has been rarely evaluated and limited documented. Therefore, we need studies to examine the methodology in how we can train nurses in the ED to take more responsibility for assessing and treating patients.

In the study we aime to;

  1. describe a methodology for a training course for nurse led UGFNB.
  2. evaluate if the training process resulted in a safe and successful UGFNB.

Data which will be collected are

  1. ASA classification (ASA Physical Status Classification System )
  2. Length of stay
  3. Morbidity

    • Hospital acquired pneumonia
    • Acute myocardial infarction (AMI)
    • Acute renal failure
    • Respiratory failure
  4. Complication rate, number of;

    • intravasal injection - visually + circulatory and neurological symptoms
    • hematoma - defined as a new tumor > 2 cm in the groin / injection site measured by ultrasound
    • Neurologic systemic outcomes / symptoms / paresthesia that have occurred after admission and which persist until discharge.
    • Allergic reaction
  5. Number of total morphine equivalents, mg (iv/po) administered prehospital and during Emergency Department stay
  6. Patients physical characteristic (physical examination; gender, age, height, weight, , blood pressure, heart rate, SpO2 (oxygen saturation) and use of oxygen will be noted together with current disease

A short, but personal interview with the patients having received an UGFNB by a study nurse can describe both the service received and the patient's experience with it. The interviews will be performed after the patient has been relieved of pain. The PhD (Philosophiae Doctor)-candidate, not the study nurse having performed the nerve block, will conduct the interviews. The patients will be asked whether the nerve block relieved them of pain, how they experienced the procedure and the fact that it was performed by a nurse had any relevance. Also, the PhD-candidate will interview the patient at a later point during the hospital stay for a second time to compare the answers

The study nurses and the anesthesiologists that has supervised the nurses will be presented with a questionnaire after each UGFNB conducted. The PhD-candidate will hand out the questionnaire immediately after the FNB is conducted by a study nurse. The items in the questionnaire include feasibility and success of the procedure and are identical for nurses and anesthesiologists.

Finally, each study nurse will do three UGFNB with supervision by an anesthesiologist before we start inclusion in a later randomized controlled trial. Five study nurses will be included and fifteen patients.

The inclusion criteria for patients will be:

  • Patients arriving at the ED diagnosed with a hip fracture (radiological confirmed)
  • ASA- classification 1-4
  • Written and verbal informed consent by patient

Exclusion criteria for patients will be:

  • Patients with; dementia, without ability to give informed consent and other cognitively challenges needed to participate in this study (at the discretion of the study nurse)
  • Known allergies to local anesthetic (Ropivacaine) used in UGFNB
  • Use of anticoagulants or platelet inhibitors. Acetylsalicylic acid and dipyridamole is allowed. If a recent (last 2 hours) INR( international normalized ratio) is below <1.5 the patient can be included.
  • Pregnant
  • Age <18 years
  • Severe head injury which leads to significant loss of consciousness (GCS <12)
  • >10 mg or more morphine administrated pre-hospital
  • Skin lesions/infection at presumed block site
  • Patients admitted with other suspected or verified fractures, except small fractures in hands and foots.

Verbal and written informed consent The study nurses will inform the patients by oral and written information and inclusion and intervention of the patient will start after written consent.

Opintotyyppi

Interventio

Ilmoittautuminen (Todellinen)

5

Vaihe

  • Ei sovellettavissa

Yhteystiedot ja paikat

Tässä osiossa on tutkimuksen suorittajien yhteystiedot ja tiedot siitä, missä tämä tutkimus suoritetaan.

Opiskelupaikat

      • Tønsberg, Norja, 3103
        • Vestfold Hospital Trust

Osallistumiskriteerit

Tutkijat etsivät ihmisiä, jotka sopivat tiettyyn kuvaukseen, jota kutsutaan kelpoisuuskriteereiksi. Joitakin esimerkkejä näistä kriteereistä ovat henkilön yleinen terveydentila tai aiemmat hoidot.

Kelpoisuusvaatimukset

Opintokelpoiset iät

  • Lapsi
  • Aikuinen
  • Vanhempi Aikuinen

Hyväksyy terveitä vapaaehtoisia

Joo

Sukupuolet, jotka voivat opiskella

Kaikki

Kuvaus

Inclusion Criteria:

  • Registered nurses or registered nurses with continuing education in acute nursing or geriatrics
  • The nurses need to be aware that it will increase the workload in beginning of the project.
  • Registered nurse has to be senior staff experienced i.e. worked in the ED
  • Motivated to take on a new task in the ED
  • Certificated in advanced CPR
  • Familiar with routines in the ED and the relevant patient group
  • They must be willing to be a part of this project for approximately 12 months.
  • Working at least 75%.

Exclusion Criteria:

  • Refuse to participate

Opintosuunnitelma

Tässä osiossa on tietoja tutkimussuunnitelmasta, mukaan lukien kuinka tutkimus on suunniteltu ja mitä tutkimuksella mitataan.

Miten tutkimus on suunniteltu?

Suunnittelun yksityiskohdat

  • Ensisijainen käyttötarkoitus: Terveyspalvelututkimus
  • Jako: Ei käytössä
  • Inventiomalli: Yksittäinen ryhmätehtävä
  • Naamiointi: Ei mitään (avoin tarra)

Aseet ja interventiot

Osallistujaryhmä / Arm
Interventio / Hoito
Muut: Emergency nurses
Emergency nurses who are trained in an one-day course
Emergency nurses who are trained for one-day in ultrasound-guided femoral nerve block

Mitä tutkimuksessa mitataan?

Ensisijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Cumulative Numerical Rating Scale (NRS) - during passive movement at 120 minutes after start of procedure, measured by 5 timepoints
Aikaikkuna: 120 minutes
Cumulative Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED at 120 minutes after admission, measured by five time Points; At the end of procedure, 30 min.-, 60 min.-, 90 min.- and 120 min after start of procedure. NRS score: 0 is no pain and 10 is the worst pain.
120 minutes

Toissijaiset tulostoimenpiteet

Tulosmittaus
Toimenpiteen kuvaus
Aikaikkuna
Hematooma
Aikaikkuna: 24 tuntia
Hematooma - määritellään uudeksi kasvaimeksi > 2 senttimetriä nivusissa/pistoskohdassa ultraäänellä mitattuna, kyllä ​​tai ei
24 tuntia
Numerical Rating Scale (NRS) - during passive movement at baseline
Aikaikkuna: At baseline (timepoint 0)
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED at baseline (inclution of patient) NRS score: 0 is no pain and 10 is the worst pain.
At baseline (timepoint 0)
Numerical Rating Scale (NRS) - during passive movement after 30 minutes
Aikaikkuna: After 30 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 30 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 30 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement after 60 minutes
Aikaikkuna: After 60 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 60 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 60 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement after 90 minutes
Aikaikkuna: After 90 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 90 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 90 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement after 120 minutes
Aikaikkuna: After 120 minutes from baseline
Numerical Rating Scale (NRS) - during passive movement (30 degree flexion in the fractured hip) in patients with hip fracture during stay in the ED after 120 minutes from baseline NRS score: 0 is no pain and 10 is the worst pain.
After 120 minutes from baseline
Intravasal injection
Aikaikkuna: 24 hours
Intravasal injection - visually + circulatory and neurological symptoms, yes or no
24 hours
Patient experience- description of pain
Aikaikkuna: 24 hours
Patient experience of pain- During rest and motion measured by a 1-5 scale
24 hours
Patient satisfaction- waiting time to pain relief
Aikaikkuna: 24 hours
Patiens experiences on waiting time to pain relief measured in a scale form 1-5
24 hours
Patient satisfaction- information
Aikaikkuna: 24 hours
Patient experiences on information measured in a scale form 1-5
24 hours
Patient satisfaction- description of pain before the procedure
Aikaikkuna: 24 hours
Patient experience on pre-procedure pain measured by 1-5 scale
24 hours
Patient satisfaction- description of pain after the procedure
Aikaikkuna: 24 hours
Patient satisfaction- description of pain after the procedure measured by 1-5 scale
24 hours
Patient satisfaction- safety
Aikaikkuna: 24 hours
Patient satisfaction- description of patient reported feeling of safety during nurse led procedure measured by a 1-5 scale
24 hours
Patient satisfaction-effect of procedure
Aikaikkuna: 24 hours
Patient satisfaction regarding reduction of pain after the procedure measured by a 1-5 scale
24 hours
Patient satisfaction-hearing status
Aikaikkuna: 24 hours
Patient satisfaction hearing status measured by a 1-4 scale
24 hours
Self reported-registered nurse- complexity
Aikaikkuna: approximately 2 hours
Complexity of procedure measured by scale 1-5
approximately 2 hours
Self reported-registered nurse-success
Aikaikkuna: approximately 2 hours
Success of procedure measured by 1-5 scale
approximately 2 hours
Self reported-registered nurse-Recognition of anatomic structures
Aikaikkuna: approximately 2 hours
Recognition of anatomic structures at ultrasound, measured by a 1-4
approximately 2 hours
Self reported-registred nurse-spread of anesthesia
Aikaikkuna: approximately 2 hours
Spread of anesthesia, measured by a 1-4 scale
approximately 2 hours
Self reported-registered nurse- patient benefit from procedure
Aikaikkuna: approximately 2 hours
Patient benefit of procedure measured by a 1-5 scale
approximately 2 hours
Self reported-Anesthesiologist-complexity
Aikaikkuna: approximately 2 hours
Complexity of procedure measured by scale 1-5
approximately 2 hours
Self reported-Anesthesiologist-success
Aikaikkuna: approximately 2 hours
Success of procedure measured by a 1-5 scale
approximately 2 hours
Self reported-Anesthesiologist-Recognition of anatomic structures
Aikaikkuna: approximately 2 hours
Recognition of anatomic structures at ultrasound measured by a 1-4 scale
approximately 2 hours
Self reported-Anesthesiologist-spread of anesthesia
Aikaikkuna: approximately 2 hours
Spread of anesthesia, measured by a 1-4 scale
approximately 2 hours
Self reported-Anesthesiologist-Patient benefit of procedure
Aikaikkuna: approxemitely 2 hours
Patient benefit of procedure measured by a 1-5 scale
approxemitely 2 hours

Yhteistyökumppanit ja tutkijat

Täältä löydät tähän tutkimukseen osallistuvat ihmiset ja organisaatiot.

Tutkijat

  • Päätutkija: Elin Saga, nurse, The Hospital of Vestfold

Julkaisuja ja hyödyllisiä linkkejä

Tutkimusta koskevien tietojen syöttämisestä vastaava henkilö toimittaa nämä julkaisut vapaaehtoisesti. Nämä voivat koskea mitä tahansa tutkimukseen liittyvää.

Yleiset julkaisut

Opintojen ennätyspäivät

Nämä päivämäärät seuraavat ClinicalTrials.gov-sivustolle lähetettyjen tutkimustietueiden ja yhteenvetojen edistymistä. National Library of Medicine (NLM) tarkistaa tutkimustiedot ja raportoidut tulokset varmistaakseen, että ne täyttävät tietyt laadunvalvontastandardit, ennen kuin ne julkaistaan ​​julkisella verkkosivustolla.

Opi tärkeimmät päivämäärät

Opiskelun aloitus (Todellinen)

Torstai 19. syyskuuta 2019

Ensisijainen valmistuminen (Todellinen)

Torstai 30. tammikuuta 2020

Opintojen valmistuminen (Todellinen)

Keskiviikko 11. marraskuuta 2020

Opintoihin ilmoittautumispäivät

Ensimmäinen lähetetty

Torstai 12. marraskuuta 2020

Ensimmäinen toimitettu, joka täytti QC-kriteerit

Keskiviikko 2. joulukuuta 2020

Ensimmäinen Lähetetty (Todellinen)

Keskiviikko 9. joulukuuta 2020

Tutkimustietojen päivitykset

Viimeisin päivitys julkaistu (Todellinen)

Keskiviikko 9. joulukuuta 2020

Viimeisin lähetetty päivitys, joka täytti QC-kriteerit

Keskiviikko 2. joulukuuta 2020

Viimeksi vahvistettu

Tiistai 1. joulukuuta 2020

Lisää tietoa

Tähän tutkimukseen liittyvät termit

Yksittäisten osallistujien tietojen suunnitelma (IPD)

Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?

EI

IPD-suunnitelman kuvaus

No plan for sharing IPD

Lääke- ja laitetiedot, tutkimusasiakirjat

Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta

Ei

Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta

Ei

Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .

Tilaa